Axsome Therapeutics Inc (19X) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	170.99M	196.00M	191.20M	218.38M
Cost of goods sold	11.91M	12.33M	14.72M	13.56M
Cost of revenue	11.91M	12.33M	14.72M	13.56M
Research and development expenses	40.16M	48.79M	52.68M	46.23M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	150.24M	169.30M	185.00M	208.14M
Operating expense	192.00M	219.70M	239.24M	255.95M
Total operating expenses	203.92M	232.02M	253.97M	269.52M
Operating income	-32.92M	-36.02M	-62.77M	-51.14M
Other non operating income	-	-	-	-
EBT including unusual items	-47.23M	-28.13M	-64.54M	-51.19M
EBT excluding unusual items	-34.04M	-37.20M	-63.95M	-52.68M
Income tax expense	-	430.00K	-	128.00K
Effective tax rate	-	-1.53%	-	-0.25%
Other operating expenses	-	-	-	-
Net income	-47.23M	-28.56M	-64.54M	-51.31M
Net profit margin	-27.62%	-14.57%	-33.76%	-23.50%
Earnings per share	-0.94	-0.56	-1.26	-0.99
Interest and investment income	2.26M	2.04M	1.91M	1.66M
Interest expense	-3.38M	-3.21M	-3.09M	-3.20M
Net interest expenses	-1.12M	-1.17M	-1.18M	-1.54M
Depreciation and amortization charges	-	-	-	-
EBITDA	-30.51M	-33.75M	-60.40M	-48.26M
Gain or loss from assets sale	-	-	-	-

Ask anything